Locations:
Search IconSearch
January 26, 2018/Neurosciences/Research

Experience Brings Heightened Efficiency to Mobile Stroke Unit, Study Shows (Video)

Door-to-needle time improved by 26 percent from 2014 to 2017

Mobile stroke unit teams become more efficient and effective over time. That’s the implication of an analysis of Cleveland Clinic’s experience with its mobile stroke unit (MSU) over the three and a half years since its launch in July 2014 as one of the nation’s first such specialized ambulances for patients with suspected acute stroke.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The analysis, presented at the 2018 International Stroke Conference in Los Angeles, compares care process measures between the first 100 patients evaluated on the MSU in 2014 and 100 consecutive patients evaluated on the MSU in mid-2017. The groups were comparable in age and initial median NIH Stroke Scale score, and thrombolysis was used in 16 percent of patients in both cohorts.

Despite these similarities, care was consistently delivered more swiftly in the 2017 cohort, with statistically significant reductions from 2014 in median door-to-needle time, door-to-CT completion/read times, alarm-to-thrombolysis time and other measures. For example, median door-to-needle time dropped from 31 minutes in 2014 to 23 minutes in 2017 — a 26 percent improvement.

Coinvestigator Andrew Russman, DO, puts the study in context in the short video below, with some insights for others considering or launching MSUs of their own.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad